2-(((Tert-butoxy)carbonyl)amino)pentanoic acid → {1-[1-(3-oxo-butyl)-1H-imidazol-4-ylcarbamoyl]-butyl}-carbamic acid tert-butyl ester
반응식
[N+:1]([C:4]1[N:5]=[CH:6][N:7]([CH2:9][CH2:10][C:11](=[O:13])[CH3:12])[CH:8]=1)([O-])=O.[C:14]([O:18][C:19]([NH:21][CH:22]([CH2:26][CH2:27][CH3:28])[C:23](O)=[O:24])=[O:20])([CH3:17])([CH3:16])[CH3:15]>>[C:14]([O:18][C:19](=[O:20])[NH:21][CH:22]([C:23](=[O:24])[NH:1][C:4]1[N:5]=[CH:6][N:7]([CH2:9][CH2:10][C:11](=[O:13])[CH3:12])[CH:8]=1)[CH2:26][CH2:27][CH3:28])([CH3:15])([CH3:16])[CH3:17]참가 물질
3
실험 절차
4-(4-nitro-1H-imidazol-1-yl)butan-2-one was reduced and coupled with 2-[(tert-butoxycarbonyl)amino]pentanoic acid to afford the title compound; MS 353 m/z (M+1).
출처 및 근거
- ORD 기록
- ord-93300f67e484497aaf5dfd7698dcb9fa
- 출처 데이터셋
- uspto-grants-2010_08
- 특허 번호
- US07781435B2
반응 노트
불러오는 중…